United States Pharmaceuticals & Healthcare Report Q2 2013 - New Report Available
For years to come, the US pharmaceutical market will remain the most attractive to drugmakers. Considerable absolute sales figures and high expected growth are supported by a robust economy and political stability. Access to healthcare in general and medicines in particular is unmatched globally. Patients, prescribers and payers are accustomed to the newest and, by definition, most expensive therapeutics and diagnostics. The key risk to our outlook is downward pressure on healthcare spending, due to the need for the government...
View full press release